These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23857942)

  • 1. Zopolrestat as a human glyoxalase I inhibitor and its structural basis.
    Zhai J; Zhang H; Zhang L; Zhao Y; Chen S; Chen Y; Peng X; Li Q; Yuan M; Hu X
    ChemMedChem; 2013 Sep; 8(9):1462-4. PubMed ID: 23857942
    [No Abstract]   [Full Text] [Related]  

  • 2. A metabolically stable tight-binding transition-state inhibitor of glyoxalase-I.
    More SS; Vince R
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6039-42. PubMed ID: 16997560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and binding studies of bidentate Zn-chelating peptidic inhibitors of glyoxalase-I.
    More SS; Vince R
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3793-7. PubMed ID: 17513107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of a homodimeric Pseudomonas glyoxalase I enzyme reveals asymmetric metallation commensurate with half-of-sites activity.
    Bythell-Douglas R; Suttisansanee U; Flematti GR; Challenor M; Lee M; Panjikar S; Honek JF; Bond CS
    Chemistry; 2015 Jan; 21(2):541-4. PubMed ID: 25411134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyproline-rod approach to isolating protein targets of bioactive small molecules: isolation of a new target of indomethacin.
    Sato S; Kwon Y; Kamisuki S; Srivastava N; Mao Q; Kawazoe Y; Uesugi M
    J Am Chem Soc; 2007 Jan; 129(4):873-80. PubMed ID: 17243824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of human glyoxalase I--evidence for gene duplication and 3D domain swapping.
    Cameron AD; Olin B; Ridderström M; Mannervik B; Jones TA
    EMBO J; 1997 Jun; 16(12):3386-95. PubMed ID: 9218781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for 18-β-glycyrrhetinic acid as a novel non-GSH analog glyoxalase I inhibitor.
    Zhang H; Huang Q; Zhai J; Zhao YN; Zhang LP; Chen YY; Zhang RW; Li Q; Hu XP
    Acta Pharmacol Sin; 2015 Sep; 36(9):1145-50. PubMed ID: 26279158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ.
    Collier PN; Martinez-Botella G; Cornebise M; Cottrell KM; Doran JD; Griffith JP; Mahajan S; Maltais F; Moody CS; Huck EP; Wang T; Aronov AM
    J Med Chem; 2015 Jan; 58(1):517-21. PubMed ID: 24754609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T; Petrash JM
    Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of the aldose reductase-inhibitor complex based on the X-ray crystal structure and studies with single-site-directed mutants.
    Singh SB; Malamas MS; Hohman TC; Nilakantan R; Carper DA; Kitchen D
    J Med Chem; 2000 Mar; 43(6):1062-70. PubMed ID: 10737739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
    El-Kabbani O; Ramsland P; Darmanin C; Chung RP; Podjarny A
    Proteins; 2003 Feb; 50(2):230-8. PubMed ID: 12486717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors.
    Chiba T; Ohwada J; Sakamoto H; Kobayashi T; Fukami TA; Irie M; Miura T; Ohara K; Koyano H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7486-9. PubMed ID: 23122816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of human glyoxalase I and its complex with TLSC702 reveal inhibitor binding mode and substrate preference.
    Usami M; Ando K; Shibuya A; Takasawa R; Yokoyama H
    FEBS Lett; 2022 Jun; 596(11):1458-1467. PubMed ID: 35363883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight-binding inhibitors efficiently inactivate both reaction centers of monomeric Plasmodium falciparum glyoxalase 1.
    Urscher M; More SS; Alisch R; Vince R; Deponte M
    FEBS J; 2012 Jul; 279(14):2568-78. PubMed ID: 22607473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic mechanism of glyoxalase I: a theoretical study.
    Himo F; Siegbahn PE
    J Am Chem Soc; 2001 Oct; 123(42):10280-9. PubMed ID: 11603978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
    Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
    J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat.
    Wilson DK; Tarle I; Petrash JM; Quiocho FA
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9847-51. PubMed ID: 8234324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalent transition-state analogue inhibitors of human glyoxalase I.
    Zheng ZB; Creighton DJ
    Org Lett; 2003 Dec; 5(25):4855-8. PubMed ID: 14653691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel bivalent inhibitors with sub-nanomolar affinities towards human glyoxalase I.
    Sang Y; Shi Q; Mo M; Ni C; Li Z; Liu B; Deng Q; Creighton DJ; Zheng ZB
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4724-4727. PubMed ID: 26320622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of pharmacophore modeling and 3D-QSAR analysis of potential glyoxalase-I inhibitors as anticancer agents.
    Al-Sha'er MA; Al-Balas QA; Hassan MA; Al Jabal GA; Almaaytah AM
    Comput Biol Chem; 2019 Jun; 80():102-110. PubMed ID: 30947068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.